Shaili Desai | Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

Shaili Desai, MD

Medical Oncologist

Conditions Treated

Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

Hospitals & Clinics

Bio & Insurance Information

Insurance Accepted

Aetna Blue Cross of California Blue Shield of California Cigna Humana

Education & Training

Northeast Ohio Medical University

Medical School

University Hospital - University of Cincinnati

Residency

University Hospital - University of Cincinnati

Fellowship

Board Certifications

American Board of Internal Medicine - Oncology

Medical License

MI State Medical License: 2013 - 2018

OH State Medical License: 2012 - 2019

American Board of Internal Medicine: Medical Oncology

American Board of Internal Medicine: Hematology

American Board of Internal Medicine: Internal Medicine

Hospitals & Clinics

Publications

Dr. Shaili Desai has contributed to 1 publications.

Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.

Roddy, J. V., Partridge, S. M., Rockey, M. L., Pruemer, J. M., Guo, J. J., Desai, S. J., Safa, M. M.; Am J Clin Oncol. 2010 Feb 01.